(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know. - 2Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
- 3At least 490 protesters killed in Iran, activists say
- 4Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- 5Windows to the Previous: An Excursion Through the World's Notable Engineering
- Meet the astronauts about to make history on flight around the moon
- This Tiny Bright Yellow Frog Is One of the Most Toxic Animals on Earth
- France's Senate backs ban on social media platforms for under-15s
- FDA approves Wegovy pill for weight loss: What to know
- ‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
- He suddenly couldn't speak in space. NASA astronaut says his medical scare remains a mystery
- Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- German diesel hits new records over Easter weekend
- Vagus nerve stimulation shows promise as a way to counter Alzheimer’s disease- and age-related memory loss
